Oncimmune is an industry leader in early cancer detection. The company is committed to advancing early cancer detection through proprietary autoantibody assay technologies based on biological technology identified by John Robertson, M.D., professor of surgery at Nottingham University, England, and chief scientific officer of Oncimmune, LTD. The company’s mission is to develop early cancer detection tests to identify more than 90 percent of solid-tumor cancers, which make up 70 percent of all cancers including lung, breast, colorectal, prostate, stomach, pancreatic and ovarian.
We invite you to view our news releases.
2013
March 18 Press Release- PCL Alverno Laboratories Launches Blood Test to Aid in the Early Detection of LUng Cancer Full Release
Feb 12 Press Release PAML Introduces Blood Test to Aid in the Early Detection of Lung Cancer Full Release
Jan 09 Press Release ARUP Laboratories Introduces Blood Test to Aid in the Early Detection of Lung Cancer Full Release
2012
Dec 05 Press Release Pathology, Inc. Introduces Blood Test to Aid in the Early Detection of Lung Cancer Full Release
Nov 13 Press Release Enzo Biochem's Clinical Labs Introduces Diagnostic Test That Assists in Early Detection of Lung Cancer Full Release
May 30 Press Release Oncimmune® USA LLC Highlights the Stories of Three Patients Diagnosed with Early Stage Lung Cancer Full Release PDF
May 3 Press Release EarlyCDT®-Lung to be Part of a Randomized Clinical Trial of Patients at High Risk for Lung Cancer, Conducted by the Scottish Government Full Release
May 1 Press Release National Jewish Health, the Nation's Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT Full Release
April 19 Press Release Oncimmune® (USA) Launches New and Improved Website Aimed to Educate Medical Professionals about the Benefits of EarlyCDT®-Lung Full Release
March 22 Press Release Major Lung Cancer Screening Trial announced by the NHS in Scotland Using an Innovative Blood Test, EarlyCDT(R) -- Lung Full Release PDF
January 19 Press Release Oncimmune® (USA) Reports a Rise in Interest Surrounding EarlyCDT®-Lung as Many Resolve to Quit Smoking in 2012 Full Release
2011
December 21 Press Release Oncimmune® (USA) LLC Experiences Increased Interest in EarlyCDT®-Lung as Doctors Place New Emphasis on Lung Cancer Screening with CT, in Response to Landmark NLST Study Full Release
December 13 Press Release Research Shows Screening with X-rays Does Not Significantly Reduce Lung Cancer Mortality, Highlights Need for Additional Cancer Detection Tools Including EarlyCDT®-Lung Full Release
November 7 Press Release Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories Full Release
October 18 Press Release Oncimmune® (USA) LLC Releases Educational Video Series in an Effort to Support National Lung Cancer Awareness Month Full Release
September 20 Press Release Oncimmune® (USA) LLC Receives Laboratory Permit to Begin Offering EarlyCDT® - Lung in the State of New York Full Release
September 13 Press Release Oncimmune® (USA) LLC Partners with Stroke Detection Plus® Making EarlyCDT™-Lung Accessible to a Larger Population of High Risk Patients Full Article
August 23 Press Release HelloHaveYouHeard.com Establishes Remarkable Web Presence and Social Media Following Full Release
July 5 Press Release First Reportable Data of EarlyCDT™-Lung Use in Clinical Practice Presented at IASLC World Conference on Lung Cancer Full Release
June 8 Press Release The EarlyCDT™-Lung, a Blood Test Which Aids in Lung Cancer Risk Assessment and Diagnosis, Reaches Two Year Anniversary of Commercial Release Date Full Release
May 11 Press Release Oncimmune® Announces Independent Research to be Conducted on their EarlyCDT™-Lung Test -- A Test Designed to Aid in Identifying Lung Cancer Release
2010
Aug. 05 New Study Demonstrates Clinical Validity of EarlyCDT-Lung Full Release
Jun. 29 Oncimmune® EarlyCDT-Lung -- a Simple Blood Test to Aid in the Early Detection of Lung Cancer -- Now Available in Canada
Jun. 1 London Times Detecting Cancer
A blood test can pick up early warnings of the disease from the immune system Article
Jun. 1 London Times Patients already experiencing benefits of the test Article
Jun. 1 London Times Oncimmune developes simple blood test for early detection of cancer Article
Jun. 1 Press Release Nottingham research leads to blood test for early detection of cancer Release
Jun. 1 Press Release Studies Demonstrate Early Stage Detection and Economic Benefits of a Blood-Based Test for Lung Cancer Release
Aug. 26, 2009 Oncimmune Launches Blood Test for Lung Cancer, SmartBrief more...